Development of Stimuli-Responsive Nanoparticles for Targeted Delivery of Encorafenib in BRAF-Mutant Cancer Therapy. International Journal of Research Development and Technology, [S. l.], v. 4, n. 1, p. 85–109, 2026. DOI: 10.62218/ijrdt.v4i1.170. Disponível em: https://ijrdt.com/index.php/files/article/view/170. Acesso em: 10 sep. 2026.